NCT02745223View on ClinicalTrials.gov

Safety, Tolerability, and Efficacy of PresbiDrops (CSF-1), a Topical Ophthalmic Drug for Presbyopia

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Presbyopia
Interventions
DRUG

PresbiDrops (CSF-1)

PresbiDrops (CSF-1) is a topical ophthalmic drug.

DRUG

Placebo

Placebo drops contains the same ingredients as PresbiDrops except for the active ingredients.

Trial Locations (1)

Unknown

The Department of Ophthalmology, Rambam Health Care Campus, Haifa

Sponsors
All Listed Sponsors
lead

Orasis Pharmaceuticals Ltd.

INDUSTRY